Shopping Cart 0
Cart Subtotal
AED 0

Gilead Sciences, Inc. - Strategy, SWOT and Corporate Finance Report

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 642

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 1285

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 1927

Details

Gilead Sciences, Inc.-Strategy, SWOT and Corporate Finance Report

Summary

Gilead Sciences, Inc.-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.

Key Highlights

Gilead Sciences, Inc. (Gilead or 'the company') is a research-based biopharmaceutical company engaged in developing and marketing therapies for HIV/AIDS, liver diseases, oncology, inflammation and serious cardiovascular and respiratory conditions. The company operates in the US, Europe and other countries. Gilead is headquartered in Foster City, California, the US.

Scope

- Detailed information on Gilead Sciences, Inc. required for business and competitor intelligence needs

- A study of the major internal and external factors affecting Gilead Sciences, Inc. in the form of a SWOT analysis

- An in-depth view of the business model of Gilead Sciences, Inc. including a breakdown and examination of key business segments

- Intelligence on Gilead Sciences, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

- News about Gilead Sciences, Inc., such as business expansion, restructuring, and contract wins

- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Gilead Sciences, Inc. and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess Gilead Sciences, Inc. as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on Gilead Sciences, Inc.'s business structure, strategy and prospects.

READ MORE

Table Of Content

Scope

Table of Contents

Company Snapshot 2

Table of Contents 5

Gilead Sciences, Inc.: Company Overview 9

Gilead Sciences, Inc.: Overview and Key Facts 9

Gilead Sciences, Inc.: Overview 9

Gilead Sciences, Inc.: Key Facts 9

Gilead Sciences, Inc.: Key Employees 11

Gilead Sciences, Inc.: Key Employee Biographies 13

Gilead Sciences, Inc.: Major Products and Services 20

Gilead Sciences, Inc.: Company History 21

Gilead Sciences, Inc.: Management Statement 28

Gilead Sciences, Inc.: Locations and Subsidiaries 31

Gilead Sciences, Inc.: Key Competitors 33

Gilead Sciences, Inc.: Company Analysis 34

Gilead Sciences, Inc.: Business Description 34

Gilead Sciences, Inc.: SWOT Analysis 35

Gilead Sciences, Inc.: SWOT Overview 35

Gilead Sciences, Inc.: Strengths 35

Gilead Sciences, Inc.: Weaknesses 36

Gilead Sciences, Inc.: Opportunities 36

Gilead Sciences, Inc.: Threats 38

Gilead Sciences, Inc.: Corporate Financial Deals Activity 40

Gilead Sciences, Inc.: Financial Deals Overview 40

Gilead Sciences, Inc.: Targets and Partners 42

Gilead Sciences, Inc.: Top Deals 2014-2018YTD* 44

Gilead Sciences, Inc.: Advisors 45

Gilead Sciences, Inc.: Top Legal Advisors 45

Gilead Sciences, Inc.: Top Financial Advisors 45

Gilead Sciences, Inc.: Mergers and Acquisitions 47

Gilead Sciences, Inc.: Corporate Venturing 48

Gilead Sciences, Inc.: Capital Raising 49

Gilead Sciences, Inc.: Partnership 50

Gilead Sciences, Inc.: Recent Developments 51

Gilead Sciences, Inc.: News and Events Summary 51

Gilead Sciences, Inc.: Business Expansion 54

Gilead Sciences, Inc.: Contracts 54

Gilead Sciences, Inc.: Corporate Governance 55

Gilead Sciences, Inc.: Financial Performance 56

Gilead Sciences, Inc.: Regulatory and Legal Events 56

Gilead Sciences, Inc.: Strategy and Operations 58

Appendix 59

Contact Us 59

Methodology 59

About MarketLine 60


List Of Figure

List of Figures

Figure 1: Gilead Sciences, Inc.: Deal Activity by Deal Type-Volume (TTM*)

Figure 2: Gilead Sciences, Inc.: M&A Activity by Geography (TTM*)

Figure 3: Gilead Sciences, Inc.: Deal Activity by Deal Type-Volume (2014-YTD*2018)

Figure 4: Gilead Sciences, Inc.: M&A Average Deal Size-Value (USUSDm)

Figure 5: Gilead Sciences, Inc.: M&A Volume and Value Trend (2014-YTD*2018)

Figure 6: Gilead Sciences, Inc.: M&A Activity by Geography (2014-YTD*2018)

Figure 7: Gilead Sciences, Inc.: Corporate Venturing Volume and Value Trend (2014-YTD*2018)

Figure 8: Gilead Sciences, Inc.: Corporate Venturing by Geography (2014-YTD*2018)

Figure 9: Gilead Sciences, Inc.: Capital Raising Volume and Value Trend (2014-YTD*2018)

Figure 10: Gilead Sciences, Inc.: Capital Raising by Deal Type (2014-YTD*2018)

Figure 11: Gilead Sciences, Inc.: Partnership Volume and Value Trend (2014-YTD*2018)

Figure 12: Gilead Sciences, Inc.: Partnership Trend by Deal Type (2014-YTD*2018)


List Of Table

List of Tables

Table 1: Gilead Sciences, Inc.: Key Facts

Table 2: Gilead Sciences, Inc.: Key Employees

Table 3: Gilead Sciences, Inc.: Locations and Subsidiaries

Table 4: Gilead Sciences, Inc.: Key Competitors

Table 5: Gilead Sciences, Inc.: Deal Activity by Deal Type-Volume (TTM*)

Table 6: Gilead Sciences, Inc.: M&A Activity by Geography (TTM*)

Table 7: Gilead Sciences, Inc.: Deal Activity by Deal Type-Volume (2014-YTD*2018)

Table 8: Gilead Sciences, Inc.: M&A Average Deal Size-Value (USUSDm)

Table 9: Gilead Sciences, Inc.: Targets and Partners

Table 10: Gilead Sciences, Inc.: Top Deals 2014-2018YTD*

Table 11: Gilead Sciences, Inc.: Legal Advisor Ranking by Value (USUSDm)

Table 12: Gilead Sciences, Inc.: Financial Advisor Ranking by Value (USUSDm)

Table 13: Gilead Sciences, Inc.: M&A Volume and Value Trend (2014-YTD*2018)

Table 14: Gilead Sciences, Inc.: M&A Activity by Geography (2014-YTD*2018)

Table 15: Gilead Sciences, Inc.: Corporate Venturing Volume and Value Trend (2014-YTD*2018)

Table 16: Gilead Sciences, Inc.: Corporate Venturing by Geography (2014-YTD*2018)

Table 17: Gilead Sciences, Inc.: Capital Raising Volume and Value Trend (2014-YTD*2018)

Table 18: Gilead Sciences, Inc.: Capital Raising by Deal Type (2014-YTD*2018)

Table 19: Gilead Sciences, Inc.: Partnership Volume and Value Trend (2014-YTD*2018)

Table 20: Gilead Sciences, Inc.: Partnership Trend by Deal Type (2014-YTD*2018)

Table 21: Gilead Sciences, Inc.: News and Events Summary

Table 22: Gilead Sciences, Inc.: Business Expansion

Table 23: Gilead Sciences, Inc.: Contracts

Table 24: Gilead Sciences, Inc.: Corporate Governance

Table 25: Gilead Sciences, Inc.: Financial Performance

Table 26: Gilead Sciences, Inc.: Regulatory and Legal Events

Table 27: Gilead Sciences, Inc.: Strategy and Operations

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

Gilead Sciences, Inc.-Strategy, SWOT and Corporate Finance Report

Summary

Gilead Sciences, Inc.-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.

Key Highlights

Gilead Sciences, Inc. (Gilead or 'the company') is a research-based biopharmaceutical company engaged in developing and marketing therapies for HIV/AIDS, liver diseases, oncology, inflammation and serious cardiovascular and respiratory conditions. The company operates in the US, Europe and other countries. Gilead is headquartered in Foster City, California, the US.

Scope

- Detailed information on Gilead Sciences, Inc. required for business and competitor intelligence needs

- A study of the major internal and external factors affecting Gilead Sciences, Inc. in the form of a SWOT analysis

- An in-depth view of the business model of Gilead Sciences, Inc. including a breakdown and examination of key business segments

- Intelligence on Gilead Sciences, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

- News about Gilead Sciences, Inc., such as business expansion, restructuring, and contract wins

- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Gilead Sciences, Inc. and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess Gilead Sciences, Inc. as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on Gilead Sciences, Inc.'s business structure, strategy and prospects.

READ MORE

Scope

Table of Contents

Company Snapshot 2

Table of Contents 5

Gilead Sciences, Inc.: Company Overview 9

Gilead Sciences, Inc.: Overview and Key Facts 9

Gilead Sciences, Inc.: Overview 9

Gilead Sciences, Inc.: Key Facts 9

Gilead Sciences, Inc.: Key Employees 11

Gilead Sciences, Inc.: Key Employee Biographies 13

Gilead Sciences, Inc.: Major Products and Services 20

Gilead Sciences, Inc.: Company History 21

Gilead Sciences, Inc.: Management Statement 28

Gilead Sciences, Inc.: Locations and Subsidiaries 31

Gilead Sciences, Inc.: Key Competitors 33

Gilead Sciences, Inc.: Company Analysis 34

Gilead Sciences, Inc.: Business Description 34

Gilead Sciences, Inc.: SWOT Analysis 35

Gilead Sciences, Inc.: SWOT Overview 35

Gilead Sciences, Inc.: Strengths 35

Gilead Sciences, Inc.: Weaknesses 36

Gilead Sciences, Inc.: Opportunities 36

Gilead Sciences, Inc.: Threats 38

Gilead Sciences, Inc.: Corporate Financial Deals Activity 40

Gilead Sciences, Inc.: Financial Deals Overview 40

Gilead Sciences, Inc.: Targets and Partners 42

Gilead Sciences, Inc.: Top Deals 2014-2018YTD* 44

Gilead Sciences, Inc.: Advisors 45

Gilead Sciences, Inc.: Top Legal Advisors 45

Gilead Sciences, Inc.: Top Financial Advisors 45

Gilead Sciences, Inc.: Mergers and Acquisitions 47

Gilead Sciences, Inc.: Corporate Venturing 48

Gilead Sciences, Inc.: Capital Raising 49

Gilead Sciences, Inc.: Partnership 50

Gilead Sciences, Inc.: Recent Developments 51

Gilead Sciences, Inc.: News and Events Summary 51

Gilead Sciences, Inc.: Business Expansion 54

Gilead Sciences, Inc.: Contracts 54

Gilead Sciences, Inc.: Corporate Governance 55

Gilead Sciences, Inc.: Financial Performance 56

Gilead Sciences, Inc.: Regulatory and Legal Events 56

Gilead Sciences, Inc.: Strategy and Operations 58

Appendix 59

Contact Us 59

Methodology 59

About MarketLine 60


List Of Figure

List of Figures

Figure 1: Gilead Sciences, Inc.: Deal Activity by Deal Type-Volume (TTM*)

Figure 2: Gilead Sciences, Inc.: M&A Activity by Geography (TTM*)

Figure 3: Gilead Sciences, Inc.: Deal Activity by Deal Type-Volume (2014-YTD*2018)

Figure 4: Gilead Sciences, Inc.: M&A Average Deal Size-Value (USUSDm)

Figure 5: Gilead Sciences, Inc.: M&A Volume and Value Trend (2014-YTD*2018)

Figure 6: Gilead Sciences, Inc.: M&A Activity by Geography (2014-YTD*2018)

Figure 7: Gilead Sciences, Inc.: Corporate Venturing Volume and Value Trend (2014-YTD*2018)

Figure 8: Gilead Sciences, Inc.: Corporate Venturing by Geography (2014-YTD*2018)

Figure 9: Gilead Sciences, Inc.: Capital Raising Volume and Value Trend (2014-YTD*2018)

Figure 10: Gilead Sciences, Inc.: Capital Raising by Deal Type (2014-YTD*2018)

Figure 11: Gilead Sciences, Inc.: Partnership Volume and Value Trend (2014-YTD*2018)

Figure 12: Gilead Sciences, Inc.: Partnership Trend by Deal Type (2014-YTD*2018)


List Of Table

List of Tables

Table 1: Gilead Sciences, Inc.: Key Facts

Table 2: Gilead Sciences, Inc.: Key Employees

Table 3: Gilead Sciences, Inc.: Locations and Subsidiaries

Table 4: Gilead Sciences, Inc.: Key Competitors

Table 5: Gilead Sciences, Inc.: Deal Activity by Deal Type-Volume (TTM*)

Table 6: Gilead Sciences, Inc.: M&A Activity by Geography (TTM*)

Table 7: Gilead Sciences, Inc.: Deal Activity by Deal Type-Volume (2014-YTD*2018)

Table 8: Gilead Sciences, Inc.: M&A Average Deal Size-Value (USUSDm)

Table 9: Gilead Sciences, Inc.: Targets and Partners

Table 10: Gilead Sciences, Inc.: Top Deals 2014-2018YTD*

Table 11: Gilead Sciences, Inc.: Legal Advisor Ranking by Value (USUSDm)

Table 12: Gilead Sciences, Inc.: Financial Advisor Ranking by Value (USUSDm)

Table 13: Gilead Sciences, Inc.: M&A Volume and Value Trend (2014-YTD*2018)

Table 14: Gilead Sciences, Inc.: M&A Activity by Geography (2014-YTD*2018)

Table 15: Gilead Sciences, Inc.: Corporate Venturing Volume and Value Trend (2014-YTD*2018)

Table 16: Gilead Sciences, Inc.: Corporate Venturing by Geography (2014-YTD*2018)

Table 17: Gilead Sciences, Inc.: Capital Raising Volume and Value Trend (2014-YTD*2018)

Table 18: Gilead Sciences, Inc.: Capital Raising by Deal Type (2014-YTD*2018)

Table 19: Gilead Sciences, Inc.: Partnership Volume and Value Trend (2014-YTD*2018)

Table 20: Gilead Sciences, Inc.: Partnership Trend by Deal Type (2014-YTD*2018)

Table 21: Gilead Sciences, Inc.: News and Events Summary

Table 22: Gilead Sciences, Inc.: Business Expansion

Table 23: Gilead Sciences, Inc.: Contracts

Table 24: Gilead Sciences, Inc.: Corporate Governance

Table 25: Gilead Sciences, Inc.: Financial Performance

Table 26: Gilead Sciences, Inc.: Regulatory and Legal Events

Table 27: Gilead Sciences, Inc.: Strategy and Operations

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS